Study guide
20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
Key Takeaways Explain This Topic AI
Enteric fever classically shows fever with relative bradycardia (Faget sign), leucopenia and rose spots, and is confirmed by blood culture rather than serology.
Dengue causes thrombocytopenia and leucopenia with a positive tourniquet test, and NSAIDs should be avoided because of haemorrhagic risk.
Amoebic liver abscess is typically a solitary right lobe abscess with anchovy-sauce aspirate, treated with metronidazole followed by a luminal amoebicide such as paromomycin.
Last updated: September 2026
3. Enteric Fever (Typhoid & Paratyphoid Fevers)
Enteric fever is a systemic invasive bacteriological infection caused by Salmonella enterica subspecies enterica serovars Typhi and Paratyphi (A, B, and C) . Transmission occurs via the faecal-oral route through ingestion of food or water contaminated with human excreta, predominantly in South Asia (India, Pakistan, Bangladesh), Southeast Asia, and sub-Saharan Africa. The incubation period spans 7 to 21 days (1–3 weeks) .
Clinical Manifestations by Week of Illness
Week 1 (Bacteraemic Phase): Insidious onset of a 'stepwise' or 'ladder-like' climbing remittent fever, throbbing frontal headache, dry cough, malaise, and constipation (more common than diarrhoea in adults initially). Physical examination demonstrates relative bradycardia (Faget's sign / sphygmocaloric dissociation) , where the pulse rate is inappropriately low for the degree of pyrexia.
Week 2 (Lymphoid Hyperplasia & Organ Seeding): Sustained high plateau pyrexia ( 39 – 40 ∘ C 39\text{–}40^\circ\text{C} 39 – 4 0 ∘ C ), abdominal distension, right lower quadrant tenderness, and hepatosplenomegaly. In approximately 30 % 30\% 30% of light-skinned patients, transient 'rose spots' appear: subtle, 2–4 mm, blanching salmon-pink macules concentrated on the anterior chest and abdomen that resolve within 3 to 5 days. Constipation gives way to foul-smelling, green 'pea-soup' diarrhoea .
Week 3 (Complication Phase — The "Typhoid State"): Severe toxaemia, profound delirium ('coma vigil' / muttering delirium), and high risk of life-threatening gastrointestinal complications arising from necrosis and ulceration of hyperplastic Peyer's patches in the terminal ileum :
Intestinal Haemorrhage: Rapid drop in haemoglobin, melena, or haematochezia.
Ileal Perforation: Acute peritonitis with sudden severe abdominal pain, guarding, tachycardia, and free subdiaphragmatic gas on erect abdominal radiography.
Diagnostic Culture Yields & Antimicrobial Resistance
Diagnostic Sensitivity Across Stages:
Blood Culture: Diagnostic in Week 1 ( 60 – 80 % 60\text{–}80\% 60 – 80% sensitivity), dropping to < 30 % < 30\% < 30% by Week 3.
Stool Culture: Positive in Week 2 and Week 3 ( 50 – 60 % 50\text{–}60\% 50 – 60% ), reflecting biliary excretion and sloughing of Peyer's patches.
Urine Culture: Positive in Week 3 ( 25 % 25\% 25% ).
Bone Marrow Aspirate Culture: The single most sensitive diagnostic test ( > 90 % > 90\% > 90% ) throughout all stages of illness; remains positive even after 5 days of prior antibiotic therapy.
Note: The historical Widal agglutination serological test is obsolete due to abysmal sensitivity and cross-reactivity.
Antimicrobial Therapy (BIA Guidance):
High rates of fluoroquinolone resistance (ciprofloxacin / ofloxacin) secondary to gyrA mutations exist throughout Asia.
First-Line Regimen: Intravenous ceftriaxone ( 2 g 2\text{ g} 2 g once daily for 10–14 days) for severe/hospitalized disease, or oral azithromycin ( 1 g 1\text{ g} 1 g daily on Day 1, then 500 mg 500\text{ mg} 500 mg daily for 6 days) for uncomplicated illness.
- 4. Arboviral Infections & Zoonoses: Dengue & Leptospirosis
- Dengue Fever
Virology & Transmission: Flavivirus (4 antigenically distinct serotypes: DENV 1–4) transmitted by the diurnal (daytime-biting) urban mosquitoes Aedes aegypti and Aedes albopictus .
Classic Dengue ("Breakbone Fever"): Sudden high fever, retro-orbital pain exacerbated by eye movement, intense myalgias and arthralgias ("breakbone"), facial flushing, leukopenia, and thrombocytopenia. An evanescent macular erythema evolves into a characteristic maculopapular rash sparing small circular areas, famously described as "islands of white in a sea of red" .
Severe Dengue (Dengue Shock Syndrome):
Paradoxically develops during the critical defervescence phase (Days 3 to 7) as the fever drops.
Pathophysiology: Antibody-Dependent Enhancement (ADE) . Prior infection with one DENV serotype produces non-neutralizing cross-reactive IgG antibodies. Upon secondary infection with a different serotype, these antibodies bind virions and facilitate massive uptake into monocytes via Fc receptors, triggering catastrophic macrophage activation, cytokine storm, and diffuse microvascular permeability.
Hallmarks: Marked plasma leakage causing ascites, pleural effusions, severe haemoconcentration (haematocrit rise ≥ 20 % \ge 20\% ≥ 20% ) , profound thrombocytopenia ( < 100 × 10 9 /L < 100 \times 10^9\text{/L} < 100 × 1 0 9 /L ) , and hypovolaemic shock.
Management: Meticulous fluid resuscitation with isotonic crystalloids guided by haematocrit monitoring. Avoid NSAIDs/aspirin (increases haemorrhage risk).
Leptospirosis (Weil's Disease)
Transmission: Caused by the spirochaete Leptospira interrogans . Acquired through mucosal or abraded skin contact with freshwater, damp soil, or canal water contaminated with the urine of infected rodents (rats) or cattle. High risk in kayakers, canoeists, triathletes, sewer workers, and flood survivors.
Clinical Presentation:
Anicteric Leptospirosis ( 90 % 90\% 90% ): Biphasic illness: acute septicaemic phase with high fever, severe headache, and intense calf and lumbar muscle tenderness , accompanied by pathognomonic conjunctival suffusion (diffuse scleral hyperaemia without purulent exudate ).
Icteric Leptospirosis (Weil's Disease, 10 % 10\% 10% ): Severe, potentially fatal form characterized by the triad of:
Deep Jaundice: Disproportionately high conjugated bilirubin with only mild-to-moderate transaminase elevation (direct bilirubin-transaminase dissociation).
Acute Kidney Injury: Severe oliguric or non-oliguric tubulointerstitial nephritis, classically with hypokalaemia early in disease due to impaired proximal tubular sodium reabsorption.
Pulmonary Haemorrhage / ARDS: Severe alveolar haemorrhage presenting with hemoptysis and bilateral infiltrates.
Diagnosis: Microscopic Agglutination Test (MAT), blood/urine PCR.
Treatment: Intravenous ceftriaxone ( 1 – 2 g 1\text{–}2\text{ g} 1 – 2 g daily) or intravenous benzylpenicillin for severe disease; oral doxycycline for mild illness.
- 5. Tissue Parasitic Infections: Amoebic Abscess & Schistosomiasis
- Amoebic Liver Abscess vs. Pyogenic Liver Abscess
Diagnostic Characteristic Amoebic Liver Abscess Pyogenic (Bacterial) Liver Abscess
Primary Aetiology Protozoan: Entamoeba histolytica Polymicrobial: Escherichia coli , Klebsiella pneumoniae , Enterococcus , Streptococcus milleri group, anaerobes
Demographics & Exposure Young-to-middle-aged travellers or immigrants from endemic regions (Central/South America, Africa, India) Older adults ( > 60 years > 60\text{ years} > 60 years ); underlying biliary tract disease, gallstones, diverticulitis, or colorectal malignancy
Abscess Number & Anatomy Solitary ( > 80 % > 80\% > 80% ), large , localized predominantly in the posterosuperior right lobe (adjacent to diaphragm) Multiple ( > 50 % > 50\% > 50% ), scattered bilaterally throughout hepatic parenchyma
Aspirate Characteristics Sterile, odourless, reddish-brown thick paste resembling "anchovy paste" or "chocolate sauce" (liquefied necrotic hepatocytes) Purulent, foul-smelling white/yellow frank pus containing viable bacteria and polymorphonuclear neutrophils
Serology & Microscopy Amoebic serology positive in > 95 % > 95\% > 95% ; stool microscopy often negative for cysts/trophozoites by the time abscess forms Amoebic serology negative; blood and pus cultures grow enteric bacteria
Pharmacotherapy Two-Stage Regimen: ; 1. Oral Metronidazole ( 750 – 800 mg 750\text{–}800\text{ mg} 750 – 800 mg TDS for 7–10 days) to eradicate invasive tissue trophozoites, FOLLOWED IMMEDIATELY BY ; 2. A luminal amoebicide (oral paromomycin 30 mg/kg/day 30\text{ mg/kg/day} 30 mg/kg/day for 10 days, or diloxanide furoate) to eradicate persistent asymptomatic colonic cyst carriage and prevent relapse. Intravenous broad-spectrum antimicrobials (e.g., piperacillin-tazobactam or ceftriaxone + metronidazole) for 4–6 weeks PLUS mandatory percutaneous catheter drainage .
Schistosomiasis (Bilharzia)
Acquired by wading, swimming, or bathing in freshwater lakes (e.g., Lake Malawi, Lake Victoria) containing intermediate host aquatic snails ( Bulinus or Biomphalaria ). Free-swimming cercariae penetrate intact human skin, transform into schistosomulae , and migrate through the lungs to the portal venous system.
Acute Schistosomiasis (Katayama Fever): An immune-complex hypersensitivity syndrome developing 2 to 8 weeks post-exposure as adult flukes begin laying eggs. Characterized by sudden fever, urticaria, dry cough, wheeze, hepatosplenomegaly, and striking peripheral blood eosinophilia .
Chronic Schistosomiasis by Species:
Schistosoma haematobium (Urinary Schistosomiasis): Adult flukes inhabit the vesical and pelvic venous plexuses. Ova traverse the bladder wall, eliciting granulomatous inflammation. Presents with painless terminal haematuria , dysuria, ureteric strictures, hydronephrosis, and calcification of the bladder wall on pelvic radiography. A major global risk factor for squamous cell carcinoma (SCC) of the urinary bladder (not transitional cell carcinoma).
Schistosoma mansoni & Schistosoma japonicum (Hepatosplenic Schistosomiasis): Flukes reside in the inferior and superior mesenteric venules. Ova wash back into the intrahepatic portal venules, inciting granulomatous fibrotic reactions that produce pathognomonic Symmers' pipe-stem periportal fibrosis . This leads to severe non-cirrhotic, presinusoidal portal hypertension , massive splenomegaly, and bleeding oesophageal varices, with normal baseline hepatocellular synthetic function (normal albumin and INR until late terminal bleeding).
Diagnostic Confirmation: Detection of characteristic ova in terminal urine collected between 10:00 and 14:00 ( S. haematobium : prominent terminal spine ) or stool ( S. mansoni : prominent sharp lateral spine ; S. japonicum : small, inconspicuous lateral knob).
Treatment: Oral praziquantel ( 40 mg/kg 40\text{ mg/kg} 40 mg/kg in single or divided doses, repeated at 4–6 weeks to eliminate late-maturing worms).